266 related articles for article (PubMed ID: 25822857)
41. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; Barúa RL
Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
[TBL] [Abstract][Full Text] [Related]
42. Long-term effect of Helicobacter pylori eradication on plasma homocysteine in elderly patients with cobalamin deficiency.
Marino MC; de Oliveira CA; Rocha AM; Rocha GA; Clementino NC; Antunes LF; Oliveira RA; Martins AS; Del Puerto HL; D'Almeida V; Galdieri L; Pedroso ER; Cabral MM; Nogueira AM; Queiroz DM
Gut; 2007 Apr; 56(4):469-74. PubMed ID: 17005765
[TBL] [Abstract][Full Text] [Related]
43. [Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy].
Fujisawa T; Kumagai T; Goto A; Fujimori K; Akamatsu T; Kiyosawa K
Nihon Rinsho; 1999 Jan; 57(1):101-6. PubMed ID: 10036944
[TBL] [Abstract][Full Text] [Related]
44. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
[TBL] [Abstract][Full Text] [Related]
45. Influence of Helicobacter pylori infection and the effects of its eradication on gastric emptying in non-ulcerative dyspepsia.
Murakami K; Fujioka T; Shiota K; Ito A; Fujiyama K; Kodama R; Kawasaki Y; Kubota T; Nasu M
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S93-7. PubMed ID: 8574747
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
[TBL] [Abstract][Full Text] [Related]
47. Population based Helicobacter pylori screening and eradication: advances versus side effects.
Tepes B
Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403
[TBL] [Abstract][Full Text] [Related]
48. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
[TBL] [Abstract][Full Text] [Related]
49. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
50. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
51. Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school-aged children: A randomized non-blinded trial.
Lucero Y; Lagomarcino AJ; Torres JP; Roessler P; Mamani N; George SA; Huerta N; González M; O'Ryan G M
Helicobacter; 2021 Dec; 26(6):e12853. PubMed ID: 34528337
[TBL] [Abstract][Full Text] [Related]
52. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
53. Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection.
Watanabe H; Hiraishi H; Ishida M; Kazama JJ; Terano A
J Intern Med; 2003 Nov; 254(5):439-46. PubMed ID: 14535965
[TBL] [Abstract][Full Text] [Related]
54. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
Kwon Y; Jeon S; Nam S; Shin I
Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
[TBL] [Abstract][Full Text] [Related]
55. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
[TBL] [Abstract][Full Text] [Related]
56. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
57. Serum gastrin level and pepsinogen I/II ratio as biomarker of Helicobacter pylori chronic gastritis.
Arinton IG
Acta Med Indones; 2010 Jul; 42(3):142-6. PubMed ID: 20724767
[TBL] [Abstract][Full Text] [Related]
58. Duodenal erosions after eradication of Helicobacter pylori infection.
Shiotani A; Nishioka S; Iguchi M; Yanaoka K; Okada K; Tamai H; Mantani Y; Itoh H; Graham DY
Gastrointest Endosc; 2001 Oct; 54(4):448-53. PubMed ID: 11577305
[TBL] [Abstract][Full Text] [Related]
59. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
[TBL] [Abstract][Full Text] [Related]
60. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
Takata S; Ito M; Yoshihara M; Tanaka S; Imagawa S; Haruma K; Chayama K
J Gastroenterol Hepatol; 2007 Apr; 22(4):571-6. PubMed ID: 17376053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
